Apnex Medical Inc. said on Tuesday it received approval from the Food and Drug Administration to test its device on 132 patients with a common sleep disorder that causes breathing difficulty.
The implantable device, which treats obstructive sleep apnea, is used while the patient is sleeping. The device stimulates a nerve that controls the muscles in the tongue, so the patient's airways are kept open while they sleep.
The trial will take place in 15 sites in the United States and five sites abroad in Europe and Australia.
"We're very excited," said Chas McKhann, president and CEO. "This is a huge milestone for Apnex."
Apnex Medical, based in St. Paul, was founded in 2006. It has 25 employees.
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Star Tribune
Cannabis in Minnesota
Minnesota is the 23rd state in the country to legalize recreational marijuana for adults.
Home & Garden
Even common birds like the bluebird are full of mysteries
Despite conveniently nesting in manmade nest boxes, there are still lots of areas to study for Eastern bluebirds.
ThreeSixty Journalism
ThreeSixty Journalism is leading the way in developing multicultural storytellers in the media arts industry. The program is a loudspeaker for underheard voices, where highly motivated high school students discover the power of voice and develop their own within ThreeSixty's immersive college success programming. Launched in 1971 as an Urban Journalism Workshop chapter, since 2001 the program has been part of the College of Arts and Sciences at the University of St. Thomas.
Home & Garden
Osprey are the medium-sized raptors with the 'W' wings
Elegant fishing hawks becoming a familiar sight again in the metro area.
Variety
Summer Camp Guide: Find your best ones here
Kids can learn how to program robots, play chess, speak Chinese or dance hip-hop style, among other enrichment options.